Interestingly, compared to ASCL1High SCLC cells, IGFBP5 expression is much lower in these POU2F3High cells, which might explain their addiction to IGF-1R signaling, and therefore intrinsic sensitivity to IGF-1R inhibitors. The gene discussed is IGFBP5; the disease is small cell lung carcinoma.